Foundation Medicine Inc (FMI.OQ) Key Developments | Reuters.com
Edition:
United States

Analyst Research

Report Title Price
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Foundation Medicine Inc reaffirms FY 2014 revenue guidance


Tuesday, 12 Aug 2014 04:00pm EDT 

Foundation Medicine Inc:Confirmed its prior guidance for FY 2014 revenue in the range of $52 to $58 million.FY 2014 revenue of $58 mln - Thomson Reuters I/B/E/S. 

Related Company News

Company Quote

18.29
-1.14 -5.87%
24 Jun 2016